{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:07:27Z","timestamp":1780920447941,"version":"3.54.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.cct.2025.108134","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:24:41Z","timestamp":1762331081000},"page":"108134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Rationale and design of the Adipose Dysfunction, Imaging, Physiology, and Outcomes with sodium-glucose cotransporter\u00a0\u2212\u00a02 inhibitors for Sleep Apnea (ADIPOSA) study"],"prefix":"10.1016","volume":"159","author":[{"given":"Ehimen","family":"Aneni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Rutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Opemipo","family":"Olaseni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iouri","family":"Kreinin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sui","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuoheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kingman P.","family":"Strohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Klar","family":"Yaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian J.","family":"Neeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2025.108134_bb0005","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S2213-2600(19)30198-5","article-title":"Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis","volume":"7","author":"Benjafield","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.cct.2025.108134_bb0010","series-title":"Hidden Health Crisis Costing America Billions","author":"Frost","year":"2016"},{"key":"10.1016\/j.cct.2025.108134_bb0015","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/aje\/kws342","article-title":"Increased prevalence of sleep-disordered breathing in adults","volume":"177","author":"Peppard","year":"2013","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.cct.2025.108134_bb0020","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1056\/NEJMcp1816152","article-title":"Obstructive sleep apnea in adults","volume":"380","author":"Veasey","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2025.108134_bb0025","first-page":"263","article-title":"Clinical guideline for the evaluation, management and long-term Care of Obstructive Sleep Apnea in adults","volume":"5","author":"Epstein","year":"2009","journal-title":"J. Clin. Sleep Med.: JCSM\u00a0: Off. Publ. Am. Acad. Sleep Med."},{"key":"10.1016\/j.cct.2025.108134_bb0030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1513\/pats.200708-119MG","article-title":"Adherence to continuous positive airway pressure therapy: the challenge to effective treatment","volume":"5","author":"Weaver","year":"2008","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.cct.2025.108134_bb0035","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the treatment of obstructive sleep apnea and obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2025.108134_bb0040","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/s41366-021-00752-2","article-title":"Three-year effects of bariatric surgery on obstructive sleep apnea in patients with obesity grade 1 and 2: a sub-analysis of the GATEWAY trial","volume":"45","author":"Furlan","year":"2021","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.cct.2025.108134_bb0045","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.2337\/dc20-1096","article-title":"The impact of Empagliflozin on obstructive sleep apnea and cardiovascular and renal outcomes: an exploratory analysis of the EMPA-REG OUTCOME trial","volume":"43","author":"Neeland","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cct.2025.108134_bb0050","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa2004967","article-title":"Cardiovascular outcomes with Ertugliflozin in type 2 diabetes","volume":"383","author":"Cannon","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2025.108134_bb0055","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/oby.22854","article-title":"Effects of Empagliflozin treatment on glycerol-derived hepatic gluconeogenesis in adults with obesity: a randomized clinical trial","volume":"28","author":"Neeland","year":"2020","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.cct.2025.108134_bb0060","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41387-019-0098-5","article-title":"Effect of dapagliflozin on obstructive sleep apnea in patients with type 2 diabetes: a preliminary study","volume":"9","author":"Tang","year":"2019","journal-title":"Nutr. Diabetes"},{"issue":"110","key":"10.1016\/j.cct.2025.108134_bb0065","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1152\/japplphysiol.00972.2010","article-title":"A method for measuring and modeling the physiological traits causing obstructive sleep apnea","volume":"1985","author":"Wellman","year":"2011","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.cct.2025.108134_bb0070","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1164\/rccm.201707-1435OC","article-title":"Phenotyping pharyngeal pathophysiology using polysomnography in patients with obstructive sleep apnea","volume":"197","author":"Sands","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cct.2025.108134_bb0075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00408-018-00193-1","article-title":"Predictors of continuous positive airway pressure adherence in patients with obstructive sleep apnea","volume":"197","author":"Mehrtash","year":"2019","journal-title":"Lung"},{"key":"10.1016\/j.cct.2025.108134_bb0080","doi-asserted-by":"crossref","first-page":"346","DOI":"10.5664\/jcsm.26359","article-title":"Predicting treatment adherence in obstructive sleep apnea using principles of behavior change","volume":"1","author":"Aloia","year":"2005","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.cct.2025.108134_bb0085","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.5665\/sleep.3118","article-title":"Increasing adherence to obstructive sleep apnea treatment with a group social cognitive therapy treatment intervention: a randomized trial","volume":"36","author":"Bartlett","year":"2013","journal-title":"Sleep"},{"key":"10.1016\/j.cct.2025.108134_bb0090","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40463-016-0156-0","article-title":"Trends in CPAP adherence over twenty years of data collection: a flattened curve","volume":"45","author":"Rotenberg","year":"2016","journal-title":"J. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.cct.2025.108134_bb0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0272-5231(05)70430-5","article-title":"Upper airway imaging","volume":"19","author":"Schwab","year":"1998","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.cct.2025.108134_bb0100","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1164\/rccm.201711-2171OC","article-title":"Dynamic upper airway imaging during wakefulness in obese subjects with and without sleep apnea","volume":"198","author":"Feng","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cct.2025.108134_bb0105","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1507\/endocrj.EJ17-0440","article-title":"Effect of sodium glucose cotransporter 2 inhibitors on obstructive sleep apnea in patients with type 2 diabetes","volume":"65","author":"Sawada","year":"2018","journal-title":"Endocr. J."},{"key":"10.1016\/j.cct.2025.108134_bb0110","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3390\/biomedicines12050937","article-title":"Effect of SGLT2-inhibitors on Polygraphic parameters in elderly patients affected by heart failure, type 2 diabetes mellitus, and sleep apnea","volume":"12","author":"Armentaro","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.cct.2025.108134_bb0115","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00228-024-03643-3","article-title":"DAHOS study: efficacy of dapagliflozin in treating heart failure with reduced ejection fraction and obstructive sleep apnea syndrome - a 3-month, multicenter, randomized controlled clinical trial","volume":"80","author":"Xie","year":"2024","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.cct.2025.108134_bb0120","article-title":"Ertugliflozin and incident obstructive sleep apnea: an analysis from the VERTIS CV trial","author":"Wojeck","year":"2022","journal-title":"Sleep Breath."},{"key":"10.1016\/j.cct.2025.108134_bb0125","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.2337\/db15-1356","article-title":"Shift to fatty substrate utilization in response to sodium-glucose cotransporter 2 inhibition in subjects without diabetes and patients with type 2 diabetes","volume":"65","author":"Ferrannini","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.cct.2025.108134_bb0130","article-title":"The effects of sodium-glucose cotransporter 2 inhibitors on adipose tissue in patients with type 2 diabetes: a meta-analysis of randomized controlled trials","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.cct.2025.108134_bb0135","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.sleep.2023.02.011","article-title":"Muscle and visceral fat infiltration: a potential mechanism to explain the worsening of obstructive sleep apnea with age","volume":"104","author":"D\u2019Angelo","year":"2023","journal-title":"Sleep Med."},{"key":"10.1016\/j.cct.2025.108134_bb0140","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1161\/CIRCULATIONAHA.120.048739","article-title":"Renal and cardiovascular effects of SGLT2 inhibition in combination with loop diuretics in patients with type 2 diabetes and chronic heart failure","volume":"142","author":"Mordi","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cct.2025.108134_bb0145","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1113\/jphysiol.2012.245159","article-title":"Role of nocturnal rostral fluid shift in the pathogenesis of obstructive and central sleep apnoea","volume":"591","author":"White","year":"2013","journal-title":"J. Physiol."},{"key":"10.1016\/j.cct.2025.108134_bb0150","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jsmc.2024.02.001","article-title":"Mechanical interactions between the upper airway and the lungs that affect the propensity to obstructive sleep apnea in health and chronic lung disease","volume":"19","author":"Sunwoo","year":"2024","journal-title":"Sleep Med. Clin."},{"key":"10.1016\/j.cct.2025.108134_bb0155","first-page":"632","article-title":"Mechanisms of cardiovascular benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors: a state-of-the-art review","volume":"5","author":"Lopaschuk","year":"2020","journal-title":"JACC: Basic Transl. Sci."},{"key":"10.1016\/j.cct.2025.108134_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-023-01496-3","article-title":"Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome","volume":"8","author":"Lv","year":"2023","journal-title":"Sig. Transduct Target Ther."},{"key":"10.1016\/j.cct.2025.108134_bb0165","doi-asserted-by":"crossref","first-page":"II12","DOI":"10.1161\/res.61.5_supplement.ii-12","article-title":"Neural modulation of transcapillary exchange of fluid and solutes in whole-organ preparations","volume":"61","author":"Diana","year":"1987","journal-title":"Circ. Res."},{"key":"10.1016\/j.cct.2025.108134_bb0170","doi-asserted-by":"crossref","DOI":"10.1111\/1753-0407.13526","article-title":"Efficacy and safety of bexagliflozin compared with dapagliflozin as an adjunct to metformin in Chinese patients with type 2 diabetes mellitus: a 24-week, randomized, double-blind, active-controlled, phase 3 trial","volume":"16","author":"Xie","year":"2024","journal-title":"J. Diabetes"},{"key":"10.1016\/j.cct.2025.108134_bb0175","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1111\/dom.15192","article-title":"Bexagliflozin as an adjunct to metformin for the treatment of type 2 diabetes in adults: a 24-week, randomized, double-blind, placebo-controlled trial","volume":"25","author":"Halvorsen","year":"2023","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.cct.2025.108134_bb0180","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1053\/j.ajkd.2019.03.417","article-title":"Safety and effectiveness of Bexagliflozin in patients with type 2 diabetes mellitus and stage 3a\/3b CKD","volume":"74","author":"Allegretti","year":"2019","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cct.2025.108134_bb0185","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2337\/cd23-0085","article-title":"Bexagliflozin","volume":"42","author":"Giruzzi","year":"2023","journal-title":"Clin. Diabetes"},{"key":"10.1016\/j.cct.2025.108134_bb0190","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-038856","volume":"10","author":"Sprung","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.cct.2025.108134_bb0195","series-title":"The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications. Version 3","author":"Troester","year":"2023"},{"key":"10.1016\/j.cct.2025.108134_bb0200","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1001\/jama.284.23.3015","article-title":"Longitudinal study of moderate weight change and sleep-disordered breathing","volume":"284","author":"Peppard","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.cct.2025.108134_bb0205","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1164\/rccm.202007-2906ED","article-title":"Weight loss is integral to obstructive sleep apnea management. Ten-year follow-up in sleep AHEAD","volume":"203","author":"St-Onge","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cct.2025.108134_bb0210","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/dom.13833","article-title":"A 96-week, multinational, randomized, double-blind, parallel-group, clinical trial evaluating the safety and effectiveness of bexagliflozin as a monotherapy for adults with type 2 diabetes","volume":"21","author":"Halvorsen","year":"2019","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.cct.2025.108134_bb0215","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1164\/rccm.201903-0692OC","article-title":"Effect of weight loss on upper airway anatomy and the apnea-hypopnea index. The importance of tongue fat","volume":"201","author":"Wang","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cct.2025.108134_bb0220","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1164\/rccm.201901-0014TR","article-title":"More than the sum of the respiratory events: personalized medicine approaches for obstructive sleep apnea","volume":"200","author":"Edwards","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cct.2025.108134_bb0225","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.5665\/sleep.3844","article-title":"Obstructive sleep apnea in older adults is a distinctly different physiological phenotype","volume":"37","author":"Edwards","year":"2014","journal-title":"Sleep"},{"key":"10.1016\/j.cct.2025.108134_bb0230","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1513\/AnnalsATS.201903-190OC","article-title":"Polysomnographic Endotyping to select patients with obstructive sleep apnea for Oral appliances","volume":"16","author":"Bamagoos","year":"2019","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.cct.2025.108134_bb0235","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/1573402112666160114093550","article-title":"Fluid retention and rostral fluid shift in sleep-disordered breathing","volume":"12","author":"Kasai","year":"2016","journal-title":"Curr. Hypertens. Rev."},{"key":"10.1016\/j.cct.2025.108134_bb0240","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1164\/rccm.200607-927OC","article-title":"Fluid shift by lower body positive pressure increases pharyngeal resistance in healthy subjects","volume":"174","author":"Chiu","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cct.2025.108134_bb0245","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12933-021-01237-2","article-title":"Effect of empagliflozin on ectopic fat stores and myocardial energetics in type 2 diabetes: the EMPACEF study","volume":"20","author":"Gaborit","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.cct.2025.108134_bb0250","doi-asserted-by":"crossref","first-page":"921","DOI":"10.4093\/dmj.2020.0187","article-title":"Ipragliflozin, an SGLT2 inhibitor, ameliorates high-fat diet-induced metabolic changes by upregulating energy expenditure through activation of the AMPK\/ SIRT1 pathway","volume":"45","author":"Lee","year":"2021","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.cct.2025.108134_bb0255","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s12325-019-01045-x","article-title":"Effect of Empagliflozin on free fatty acids and ketone bodies in Japanese patients with type 2 diabetes mellitus: a randomized controlled trial","volume":"36","author":"Nishimura","year":"2019","journal-title":"Adv. Ther."},{"key":"10.1016\/j.cct.2025.108134_bb0260","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1507\/endocrj.EJ17-0545","article-title":"The effectiveness of dapagliflozin for sleep-disordered breathing among Japanese patients with obesity and type 2 diabetes mellitus","volume":"65","author":"Furukawa","year":"2018","journal-title":"Endocr. J."},{"key":"10.1016\/j.cct.2025.108134_bb0265","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2025.108134_bb0270","doi-asserted-by":"crossref","first-page":"89","DOI":"10.15420\/ecr.2015.10.2.89","article-title":"Sleep-disordered breathing in heart failure","volume":"10","author":"Pearse","year":"2015","journal-title":"Eur. Cardiol."},{"key":"10.1016\/j.cct.2025.108134_bb0275","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.resp.2013.11.002","article-title":"Effect of rostral fluid shift on pharyngeal resistance in men with and without obstructive sleep apnea","volume":"192","author":"White","year":"2014","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.cct.2025.108134_bb0280","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/1479164118783756","article-title":"Effects of sodium glucose co-transporter 2 inhibitors on the kidney","volume":"15","author":"de Albuquerque Rocha","year":"2018","journal-title":"Diab. Vasc. Dis. Res."}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714425003283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714425003283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:33:12Z","timestamp":1780918392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714425003283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":56,"alternative-id":["S1551714425003283"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2025.108134","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale and design of the Adipose Dysfunction, Imaging, Physiology, and Outcomes with sodium-glucose cotransporter\u00a0\u2212\u00a02 inhibitors for Sleep Apnea (ADIPOSA) study","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2025.108134","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108134"}}